M. Million

Development of new potent agonists able to interact with two postulated subsites of the cholecystokinin CCK-B receptor

B. Roques, F. Noble, C. Garbay, 1997, Letters in Peptide Science.

New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454

A. Bado, F. Beslot, C. Garbay, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Computer modelling of new pseudopeptide CCK2 agonists

B. Maigret, A. Cartier, C. Garbay, 2002 .

Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.

B. Maigret, H. Meudal, C. Garbay, 2000, Journal of medicinal chemistry.

Inhibition of the EGF-stimulated cellular proliferation of ER 22 cells by hydroxybiphenyl derivatives.

B. Roques, B. Tocqué, C. Garbay, 1995, Journal of medicinal chemistry.